Cargando…
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983482/ https://www.ncbi.nlm.nih.gov/pubmed/35398310 http://dx.doi.org/10.1016/j.cmi.2022.03.037 |
| _version_ | 1784681984821297152 |
|---|---|
| author | Ranzani, Otavio T. Bozza, Fernando A. |
| author_facet | Ranzani, Otavio T. Bozza, Fernando A. |
| author_sort | Ranzani, Otavio T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8983482 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89834822022-04-06 Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response Ranzani, Otavio T. Bozza, Fernando A. Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-08 2022-04-06 /pmc/articles/PMC8983482/ /pubmed/35398310 http://dx.doi.org/10.1016/j.cmi.2022.03.037 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ranzani, Otavio T. Bozza, Fernando A. Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title | Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title_full | Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title_fullStr | Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title_full_unstemmed | Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title_short | Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: author's response |
| title_sort | vaccine effectiveness of chadox1 ncov-19 against covid-19 in a socially vulnerable community in rio de janeiro, brazil: author's response |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983482/ https://www.ncbi.nlm.nih.gov/pubmed/35398310 http://dx.doi.org/10.1016/j.cmi.2022.03.037 |
| work_keys_str_mv | AT ranzaniotaviot vaccineeffectivenessofchadox1ncov19againstcovid19inasociallyvulnerablecommunityinriodejaneirobrazilauthorsresponse AT bozzafernandoa vaccineeffectivenessofchadox1ncov19againstcovid19inasociallyvulnerablecommunityinriodejaneirobrazilauthorsresponse |